<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0"><channel><title>中外製薬トピックス</title><link>https://www.chugai-pharm.co.jp/news/</link><description>中外製薬の最新トピック情報</description><docs>http://www.rssboard.org/rss-specification</docs><generator>python-feedgen</generator><language>ja</language><lastBuildDate>Sat, 11 Oct 2025 16:27:42 +0000</lastBuildDate><item><title>【2025-10-10】持続性GLP-1/GIP受容体作動薬CT-388の導入契約締結について </title><link>https://www.chugai-pharm.co.jp/news/detail/20251010170000_1518.html?year=2025&amp;category=</link><description>持続性GLP-1/GIP受容体作動薬CT-388の導入契約締結について</description><guid isPermaLink="false">https://www.chugai-pharm.co.jp/news/detail/20251010170000_1518.html?year=2025&amp;category=#20251010</guid><pubDate>Fri, 10 Oct 2025 00:00:00 +0000</pubDate></item></channel></rss>